Oric Pharmaceuticals, Inc. · NASDAQ:ORIC
Viking Global Investors LP reported a 9.20% stake in Oric Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Viking Global Investors LP reported a 9.20% stake in Oric Pharmaceuticals, Inc., 6,572,700 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 9.20%
- Shares
- 6,572,700
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 11 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 9.20% | 6,572,700 |
| Viking Global Opportunities Parent GP LLC | 9.20% | 6,572,700 |
| Viking Global Opportunities GP LLC | 6.10% | 4,312,800 |
| Viking Global Opportunities Portfolio GP LLC | 6.10% | 4,312,800 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 6.10% | 4,312,800 |
| Viking Global Opportunities Drawdown GP LLC | 3.20% | 2,259,900 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 3.20% | 2,259,900 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 3.20% | 2,259,900 |
| HALVORSEN OLE ANDREAS | 9.20% | 6,572,700 |
| Ott David C. | 9.20% | 6,572,700 |
| Shabet Rose Sharon | 9.20% | 6,572,700 |
Source
Related
- Oric Pharmaceuticals, Inc.
- Viking Global Investors LP
- Oric Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Viking Global Investors LP · May 15, 2026
- Schedule 13G/A · Viking Global Investors LP · Aug 14, 2025
- Form 4 · Piscitelli Dominic · Oct 21, 2026
- Form 4 · Heyman Richard A. · Oct 2, 2026
- Form 4 · Piscitelli Dominic · Sep 29, 2026
- Form 4 · Piscitelli Dominic · Sep 25, 2026
- Form 4 · Piscitelli Dominic · Aug 28, 2026